(Q42285750)

English

Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma.

scientific article published on 20 November 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

chronic hepatitis B

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

author name string

Meirong Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Ning Qiu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Shichun Lu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Dianrong Xiu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Jianguo Yu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Xing Tai Wang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Fengmin Lu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Tong Li

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Hui Zhuang

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

publication date

20 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

85

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

219-227

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23168998%20AND%20SRC:MED&resulttype=core&format=json

18 February 2020

Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Quantitative analysis of HBV cccDNA from clinical specimens: correlation with clinical and virological response during antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatitis B virus infection--natural history and clinical consequences

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Benefits and risks of interferon therapy for hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCycler real-time PCR.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Development of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23461

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42285750&oldid=1569268100"